VCMCVC Market Cap
Menu

Somatus valuation, funding and investors

somatus.com ↗LinkedIn ↗

Somatus works in value-based kidney care management, based in McLean, United States. Founded in 2016, it has about 867 employees.

Series E
VALUATION · TODAY
$2.70B −0% after Series E
Range $210M – $4.26B · Grade D
TODAY
+12 MO
$1.00B
$2.00B
$3.00B
$4.00B
$5.00B
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Series B $11.0M
Series C $64.0M
Series D $60.1M
Series E $325M
ValuationBefore first round12-month outlook: where it points, how wide it fansHover the past: the outlook shows what was predicted then
HEADCOUNT · TODAY867 employees
+22%6m growth
+22%1y growth
+22%2y growth
500
1,000
Data from Jan 2021
TODAY
Predicted in 1 yr $2.69B −0% vs today
Predicted next raise $407M if a round comes
Winding-down probability 3%
Last round
Series E · $325M · Feb 2022
Valuation at last round
$2.50B
Headcount
867
Grade
D
Founded
2016
How VCMC values companies →

Somatus valuation today

VCMC values Somatus at $2.7B today, with a range of $210M to $4.3B and a grade of D. The valuation starts from its last funding round, a Series E round in Feb 2022.

Valuation by date (135 rows)

Each point is what the model would have shown on that date, using only what was known then; before its first round, a company is valued as a startup because it later raised.

Somatus: valuation by date, as the model would have shown it on each date
DateValuationRangePredicted in 1 yrPhaseHeadcountTrendGradeWinding-down probability
1 Jan 2016$5.51M$2.00M – $15.1M$6.60M (+20%)before first round–unknownD0%
1 Feb 2016$5.53M$2.01M – $15.2M$6.78M (+23%)before first round–unknownD0%
1 Mar 2016$5.55M$2.02M – $15.2M$6.95M (+25%)before first round–unknownD0%
1 Apr 2016$5.57M$2.03M – $15.3M$7.14M (+28%)before first round–unknownD0%
1 May 2016$5.59M$2.04M – $15.4M$7.33M (+31%)before first round–unknownD0%
1 Jun 2016$5.61M$2.04M – $15.4M$7.53M (+34%)before first round–unknownD0%
1 Jul 2016$5.64M$2.05M – $15.5M$7.72M (+37%)before first round–unknownD0%
1 Aug 2016$5.79M$2.11M – $15.9M$7.93M (+37%)before first round–unknownD0%
1 Sep 2016$5.94M$2.16M – $16.3M$8.15M (+37%)before first round–unknownD0%
1 Oct 2016$6.10M$2.22M – $16.8M$8.36M (+37%)before first round–unknownD0%
1 Nov 2016$6.26M$2.28M – $17.2M$8.59M (+37%)before first round–unknownD0%
1 Dec 2016$6.43M$2.34M – $17.7M$8.81M (+37%)before first round–unknownD0%
1 Jan 2017$6.60M$2.40M – $18.1M$9.05M (+37%)before first round–unknownD0%
1 Feb 2017$6.78M$2.47M – $18.6M$9.29M (+37%)before first round–unknownD0%
1 Mar 2017$6.94M$2.53M – $19.1M$9.52M (+37%)before first round–unknownD0%
1 Apr 2017$7.13M$2.60M – $19.6M$9.78M (+37%)before first round–unknownD0%
1 May 2017$7.32M$2.67M – $20.1M$10.0M (+37%)before first round–unknownD0%
1 Jun 2017$7.52M$2.74M – $20.7M$10.3M (+37%)before first round–unknownD0%
1 Jul 2017$7.72M$2.81M – $21.2M$10.6M (+37%)before first round–unknownD0%
1 Aug 2017$7.93M$2.89M – $21.8M$10.9M (+37%)before first round–unknownD0%
1 Sep 2017$8.14M$2.96M – $22.4M$11.2M (+37%)before first round–unknownD0%
1 Oct 2017$8.36M$3.04M – $23.0M$11.5M (+37%)before first round–unknownD0%
1 Nov 2017$8.58M$3.12M – $23.6M$11.8M (+37%)before first round–unknownD0%
1 Dec 2017$8.81M$3.21M – $24.2M$12.1M (+37%)before first round–unknownD0%
1 Jan 2018$9.05M$3.29M – $24.9M$12.4M (+37%)before first round–unknownD0%
1 Feb 2018$9.29M$3.38M – $25.5M$12.7M (+37%)before first round–unknownD0%
1 Mar 2018$9.52M$3.47M – $26.2M$13.1M (+37%)before first round–unknownD0%
1 Apr 2018$9.78M$3.56M – $26.9M$13.4M (+37%)before first round–unknownD0%
12 Apr 2018$78.7M$51.6M – $179M$118M (+50%)after a round–unknownC0%
1 May 2018$80.3M$51.6M – $179M$118M (+47%)after a round–unknownC0%
1 Jun 2018$83.1M$51.6M – $179M$118M (+42%)after a round–unknownC0%
1 Jul 2018$86.0M$51.6M – $179M$118M (+37%)after a round–unknownC0%
1 Aug 2018$89.0M$51.6M – $179M$118M (+32%)after a round–unknownC0%
1 Sep 2018$92.1M$51.6M – $179M$118M (+28%)after a round–unknownC0%
1 Oct 2018$95.2M$51.6M – $179M$118M (+24%)after a round–unknownC0%
1 Nov 2018$98.5M$51.6M – $179M$118M (+20%)after a round–unknownC0%
1 Dec 2018$102M$51.6M – $179M$118M (+16%)after a round–unknownC0%
1 Jan 2019$105M$51.6M – $179M$118M (+12%)after a round–unknownC0%
1 Feb 2019$109M$51.6M – $179M$118M (+8%)after a round–unknownC0%
1 Mar 2019$113M$51.6M – $179M$118M (+5%)after a round–unknownC0%
1 Apr 2019$117M$51.6M – $179M$118M (+1%)after a round–unknownC0%
1 May 2019$118M$50.2M – $179M$118M (0%)after a round–unknownC0%
1 Jun 2019$118M$48.0M – $179M$118M (0%)after a round–unknownC0%
1 Jul 2019$118M$46.0M – $179M$118M (0%)after a round–unknownC0%
1 Aug 2019$118M$44.0M – $179M$118M (0%)after a round–unknownC0%
1 Sep 2019$118M$42.1M – $179M$118M (0%)after a round–unknownC0%
1 Oct 2019$118M$40.4M – $179M$118M (0%)after a round–unknownC0%
1 Nov 2019$118M$38.6M – $179M$118M (0%)after a round–unknownC0%
1 Dec 2019$118M$37.0M – $179M$118M (0%)after a round–unknownC0%
1 Jan 2020$118M$35.4M – $179M$118M (0%)after a round–unknownC0%
1 Feb 2020$118M$33.9M – $179M$118M (0%)after a round–unknownC0%
1 Mar 2020$118M$32.5M – $179M$118M (0%)after a round–unknownC0%
1 Apr 2020$118M$31.1M – $179M$118M (0%)after a round–unknownC0%
1 May 2020$118M$27.4M – $179M$118M (0%)after a round–unknownC0%
1 Jun 2020$118M$26.0M – $179M$118M (0%)after a round–unknownC0%
24 Jun 2020$471M$331M – $868M$612M (+30%)after a round–unknownB0%
1 Jul 2020$473M$331M – $868M$612M (+29%)after a round–unknownB0%
1 Aug 2020$484M$331M – $868M$612M (+26%)after a round–unknownB0%
1 Sep 2020$495M$331M – $868M$612M (+24%)after a round–unknownB0%
1 Oct 2020$505M$331M – $868M$612M (+21%)after a round–unknownB0%
1 Nov 2020$517M$331M – $868M$612M (+18%)after a round–unknownB0%
1 Dec 2020$528M$331M – $868M$612M (+16%)after a round–unknownB0%
1 Jan 2021$540M$331M – $868M$612M (+13%)after a round120unknownB0%
1 Feb 2021$552M$331M – $868M$612M (+11%)after a round120unknownB0%
1 Mar 2021$563M$331M – $868M$612M (+9%)after a round120unknownB0%
1 Apr 2021$576M$331M – $868M$612M (+6%)after a round120flatB0%
1 May 2021$589M$331M – $868M$612M (+4%)after a round120flatB0%
1 Jun 2021$602M$331M – $868M$612M (+2%)after a round120flatB0%
17 Jun 2021$701M$494M – $1.3B$911M (+30%)after a round120flatB0%
1 Jul 2021$709M$494M – $1.3B$911M (+29%)after a round120flatB0%
1 Aug 2021$725M$494M – $1.3B$911M (+26%)after a round120flatB0%
1 Sep 2021$741M$494M – $1.3B$911M (+23%)after a round120flatB0%
1 Oct 2021$757M$494M – $1.3B$911M (+20%)after a round120flatB0%
1 Nov 2021$774M$494M – $1.3B$911M (+18%)after a round120flatB0%
1 Dec 2021$791M$494M – $1.3B$911M (+15%)after a round120flatB0%
1 Jan 2022$809M$494M – $1.3B$911M (+13%)after a round120flatB0%
1 Feb 2022$1.0B$670M – $1.8B$1.2B (+23%)after a round480growingB0%
24 Feb 2022$2.5B$2.2B – $3.7B$3.2B (+30%)after a round480growingA0%
1 Mar 2022$2.5B$2.2B – $3.7B$3.2B (+29%)after a round480growingA0%
1 Apr 2022$2.6B$2.2B – $3.7B$3.2B (+27%)after a round480growingA0%
1 May 2022$2.6B$2.2B – $3.7B$3.2B (+24%)after a round480growingA0%
1 Jun 2022$2.7B$2.2B – $3.7B$3.2B (+21%)after a round480growingA0%
1 Jul 2022$2.7B$2.2B – $3.7B$3.2B (+19%)after a round480growingA0%
1 Aug 2022$2.8B$2.2B – $3.7B$3.2B (+16%)after a round480growingA0%
1 Sep 2022$2.9B$2.2B – $3.7B$3.2B (+13%)after a round480growingA0%
1 Oct 2022$2.9B$2.2B – $3.7B$3.2B (+11%)after a round480growingA0%
1 Nov 2022$3.0B$2.2B – $3.7B$3.2B (+9%)after a round480unknownA0%
1 Dec 2022$3.1B$2.2B – $3.7B$3.2B (+6%)after a round480unknownA0%
1 Jan 2023$3.3B$2.2B – $4.0B$3.5B (+5%)after a round660growingB0%
1 Feb 2023$3.4B$2.2B – $4.0B$3.5B (+2%)after a round660growingB0%
1 Mar 2023$3.5B$2.2B – $4.0B$3.5B (0%)after a round660growingB0%
1 Apr 2023$3.5B$2.2B – $4.0B$3.5B (0%)after a round660growingA0%
1 May 2023$3.5B$2.2B – $4.0B$3.5B (0%)after a round660growingA0%
1 Jun 2023$3.5B$2.3B – $4.0B$3.5B (0%)after a round660growingA0%
1 Jul 2023$3.5B$2.3B – $4.0B$3.5B (0%)after a round660growingA0%
1 Aug 2023$3.5B$2.3B – $4.0B$3.5B (0%)after a round660growingA0%
1 Sep 2023$3.5B$1.7B – $4.0B$3.5B (0%)after a round660unknownB0%
1 Oct 2023$3.6B$2.1B – $4.1B$3.6B (0%)after a round730upB0%
1 Nov 2023$3.6B$2.1B – $4.1B$3.6B (0%)after a round730upB0%
1 Dec 2023$3.6B$2.1B – $4.1B$3.6B (0%)after a round730upB0%
1 Jan 2024$3.6B$2.1B – $4.1B$3.6B (0%)after a round730upB0%
1 Feb 2024$3.6B$2.1B – $4.1B$3.6B (0%)after a round730upB0%
1 Mar 2024$3.5B$1.3B – $4.1B$3.5B (0%)after a round710flatB0%
1 Apr 2024$3.5B$1.2B – $4.1B$3.5B (-1%)after a round710flatC0%
1 May 2024$3.5B$1.2B – $4.1B$3.5B (-1%)after a round710flatC0%
1 Jun 2024$3.5B$1.1B – $4.1B$3.5B (-2%)after a round710flatC0%
1 Jul 2024$3.5B$1.1B – $4.1B$3.5B (-3%)after a round710flatC0%
1 Aug 2024$3.2B$1.0B – $4.0B$2.9B (-10%)after a round710flatC14%
1 Sep 2024$3.2B$951M – $4.0B$2.9B (-10%)after a round710flatC14%
1 Oct 2024$3.2B$905M – $4.0B$2.8B (-11%)after a round710flatC14%
1 Nov 2024$3.2B$860M – $4.1B$2.8B (-12%)after a round710flatC14%
1 Dec 2024$3.2B$819M – $4.1B$2.8B (-12%)after a round710flatC14%
1 Jan 2025$3.2B$778M – $4.1B$2.7B (-13%)after a round710flatC14%
1 Feb 2025$3.2B$739M – $4.1B$2.7B (-14%)after a round710flatC14%
1 Mar 2025$3.1B$706M – $4.1B$2.7B (-14%)after a round710flatC14%
1 Apr 2025$3.1B$671M – $4.0B$2.6B (-14%)after a round710flatC14%
1 May 2025$3.1B$639M – $4.1B$2.9B (-6%)after a round710unknownC13%
1 Jun 2025$3.1B$607M – $4.1B$3.0B (-5%)after a round710unknownC12%
1 Jul 2025$3.1B$578M – $4.1B$3.0B (-5%)after a round710unknownC11%
1 Aug 2025$3.2B$549M – $4.1B$3.0B (-5%)after a round710unknownD10%
1 Sep 2025$3.2B$522M – $4.1B$3.0B (-4%)after a round710unknownD9%
1 Oct 2025$3.2B$497M – $4.1B$3.1B (-4%)after a round710unknownD8%
1 Nov 2025$3.2B$472M – $4.1B$3.1B (-4%)after a round710unknownD8%
1 Dec 2025$3.2B$450M – $4.1B$3.1B (-3%)after a round710unknownD7%
1 Jan 2026$3.3B$427M – $4.1B$3.1B (-3%)after a round710unknownD7%
1 Feb 2026$3.3B$406M – $4.1B$3.2B (-3%)after a round710unknownD6%
1 Mar 2026$3.3B$388M – $4.1B$3.2B (-2%)after a round710unknownD6%
1 Apr 2026$3.3B$368M – $4.1B$3.2B (-2%)after a round710unknownD5%
1 May 2026$3.3B$351M – $4.1B$3.3B (-1%)after a round710unknownD5%
1 Jun 2026$3.3B$333M – $4.1B$3.3B (-1%)after a round710unknownD4%
1 Jul 2026$3.3B$317M – $4.1B$3.3B (-1%)after a round710unknownD4%
1 Aug 2026$3.3B$302M – $4.1B$3.3B (-1%)after a round710unknownD4%
1 Sep 2026$3.3B$287M – $4.1B$3.3B (0%)after a round710unknownD3%
1 Oct 2026$3.5B$285M – $4.3B$3.5B (0%)after a round867unknownD3%
24 Oct 2026$2.7B$210M – $4.3B$2.7B (0%)after a round867unknownD3%

Key facts about Somatus

Founded
2016
Headquarters
McLean, United States
Employees
about 867
Total raised
$460M
Funding rounds
4
Last round
Series E Feb 2022

Somatus was founded in 2016 by Ikenna Okezie and Tony Welters.

Somatus funding history

Somatus has 4 funding rounds on record, from Apr 2018 to Feb 2022, $460M in total. The latest disclosed valuation is $2.50B post-money (Series E, Feb 2022).

  1. Series E 23 Feb 2022

    Led by Wellington Management Company; with RA Capital, GIC, Fidelity Management & Research Company, Anthem Venture Partners, Optum Ventures, Inova Health System, Blue Venture Fund, Longitude Capital, Deerfield, Flare Capital Partners.

    Sources: coverager.com, somatus.com

    $325M

    $2.50B post-money

  2. Series D 16 Jun 2021

    With Anthem Venture Partners.

    $60M

  3. Series C 23 Jun 2020

    Led by Longitude Capital, Optum Ventures, Deerfield; with Blue Venture Fund, Flare Capital Partners, Town Hall Ventures. Individuals: Dan Gebremedhin.

    Sources: somatus.com, flarecapital.com, hitconsultant.net and 2 more

    $64M

  4. Series B 11 Apr 2018

    Led by Flare Capital Partners; with Blue Venture Fund, Inova Health System, Town Hall Ventures.

    Sources: somatus.com, prnewswire.com

    $11M

Somatus investors

12 investors have backed Somatus; Flare Capital Partners, Deerfield and Longitude Capital and 2 more led at least one round.

  • Wellington Management Company lead
  • Inova Health System 2 rounds
  • Fidelity Management & Research Company
  • GIC

What Somatus does

Somatus works in home health care, with 14 recorded offerings and customers in healthcare.

Somatus, Inc. is an American company that provides value-based kidney and cardiovascular care management, including in-home care for chronic kidney disease, end-stage renal disease, and related conditions. The company operates a proprietary technology platform that utilizes AI-driven analytics to deliver personalized care. Somatus serves patients across the United States and collaborates with health plans and providers to support health equity initiatives.

Description from Veridion's company data.

Products and services

  • Value-Based Kidney Care Management
  • Value-Based Cardiovascular Care Management
  • In-Home Chronic Disease Care Delivery
  • AI-Driven Clinical Decision Support Services
  • Predictive Analytics for Patient Risk Stratification
  • Health Plan Partnership Services
  • Provider Network Integration Services
  • Individualized Patient Support Services
  • Health Equity Program Implementation
  • Chronic Condition Management Services
  • Medical Cost Reduction Solutions
  • Whole-Person Care Delivery
  • Proprietary Healthcare Technology Development
  • Healthcare Research and Development

Markets

  • Healthcare

Technology

  • AI-Driven Treatment Decision Support
  • Machine Learning for Predictive Analytics

Certifications

  • NCQA Accreditation for Health Equity

Business model

  • Business-to-Business
  • Business-to-Consumer
  • Service Provider
  • Healthcare

Industry codes (NAICS)

  • 621610 Home Health Care Services 75% match
  • 541512 Computer Systems Design Services 25% match

Questions about Somatus

What is Somatus worth?

Valuation $2.7B (range $210M to $4.3B), as of 24 Oct 2026. The last disclosed valuation was $2.50B (Series E, Feb 2022).

Has Somatus raised money?

Somatus has 4 funding rounds on record, from Apr 2018 to Feb 2022, $460M in total. The latest disclosed valuation is $2.50B post-money (Series E, Feb 2022).

Who has invested in Somatus?

Flare Capital Partners, Deerfield, Longitude Capital, Optum Ventures, Wellington Management Company and Blue Venture Fund, and 6 more. Lead investors include Flare Capital Partners, Deerfield, Longitude Capital and Optum Ventures.

How many people work at Somatus?

About 867. Headcount grew from 120 in Jan 2021 to 867 in Sep 2026.

What does Somatus do?

Somatus works in home health care, with 14 recorded offerings and customers in healthcare. Its main offerings are value-based kidney care management, value-based cardiovascular care management and in-home chronic disease care delivery.

When was Somatus founded, and where is it based?

Somatus was founded in 2016 and is based in McLean, United States. It has about 867 employees.

How we value companiesReport an issue